A preparation method of polysubstituted isoquinoline and 1,6-naphthyridine compounds and common molecular skeletons of optoelectronic materials
Isoquinoline and 1,1, were solved by reacting the phenyl o-pentanoxime ester containing a strongly coordinated azene heterocycle with a 1,2-bissubstituted olefin compound by performing the oxidative Heck reaction using a trivalent transition metal catalyst in an inert solvent. The problems of selectivity and catalyst deactivation in 6-naphthyridine synthesis have achieved efficient and economical construction of multi-substituted compounds, suitable for photoelectric materials and pharmaceutical fields.
Patent Information
- Application Number
- CN202211425590.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-11-14
- Publication Date
- 2024-11-19
- Estimated Expiration
- 2042-11-14
AI Technical Summary
The prior art has poor regio-selectivity and chemical selectivity in the synthesis of isoquinoline and 1,6-naphthyridine, which is difficult to be compatible with nitrogen-containing heterocycles, and the catalyst deactivation of strong coordination heterocycles by oxidative Heck reactions. , limiting large-scale industrial production.
The trivalent transition metal catalyst was used to carry out the oxidation Heck reaction in an inert solvent, and the phenyl o-pentanoxime ester containing a strong coordination azohexyl ring was reacted with a 1,2-double substituted olefin compound to construct a multi-substituted isohydrin by multiple dehydrogenation. Quinoline or 1,6-naphthyridine compounds, using molecular oxygen as cooxidants, overcome the limitations of strong coordination heterocycles.
Achieving efficient, atomic economic and step-by-step economical construction of multi-substituted isoquinoline and 1,6-naphthyridine compounds, compatible with strong coordination alumina heterocycles, expanding the scope of substrate application, improving the regioselectivity of the reaction and Chemiselectivity.
Smart Images

Figure CN115710249B_ABST
Abstract
Description
Technical Field
[0001] The present patent application relates to the technical field of organic compound synthesis, and more specifically, to a method for preparing polysubstituted isoquinoline and 1,6-naphthyridine compounds and a common molecular skeleton of optoelectronic materials. Background Art
[0002] Pyridine fused ring compounds are the core skeletons of material molecules, drugs and bioactive molecules, among which isoquinoline and naphthyridine are two typical molecules of this type of compound. Isoquinoline is widely present in important fields such as pesticides (quinclorac), medicines (bedaquiline), alkaloids (camptothecin), and sensitizers (quinaldine); naphthyridine is the core fragment of drug molecules (such as cilostazol), natural products (naphthyromycin), fluorescent molecular probes, and pressure-induced fluorescence color (MFC) materials. Therefore, how to construct heterocyclic pyridine compounds such as isoquinoline and naphthyridine has received widespread attention from scientists.
[0003] Among the traditional methods for synthesizing naphthyridine, the traditional methods mainly include Friedlaender reaction method synthesis (J. Heterocyclic Chem., 2004, 14, 1039), Combes reaction method synthesis (Org. Lett., 2017, 19, 6384-6387), Gould-Jacobs reaction method synthesis (Org. Process Res. Dev. 2015, 19, 399-409), etc. Such methods have long synthesis time, complex routes, low yields, etc., which are not conducive to the sustainable application of naphthyridine in the field of synthesis.
[0004] Therefore, it is worth looking forward to developing an environmentally friendly, atom-economical and step-economical new strategy to simply construct naphthyridine and isoquinoline compounds. Among them, in recent years, transition metal-catalyzed carbon-hydrogen bond activation is a better alternative and has also been applied to the synthesis of isoquinoline (J. Org. Chem., 2014, 79, 7041-7050; J. Am. Chem. Soc., 2002, 124, 11342-11348; Chem. Commun., 2015, 51, 13327-13329.), which also provides an important way to explore the efficient synthesis of quinoline natural products, drugs and functional materials.
[0005] However, the above methods still have the following challenges: 1) their regioselectivity and chemical selectivity are poor, and the product structure is limited; 2) due to the strong coordination of nitrogen heterocycles such as pyridine and pyrazole, these reactions are often incompatible with nitrogen heterocycles. The above limitations hinder the continued application of this type of method in the fields of materials and biomedicine, and restrict large-scale industrial production.
[0006] Based on the research of our group on the activation of carbon-hydrogen bonds assisted by easily converted weakly coordinating functional groups (ACS Catal., 2019, 9, 8749-8756; ChemCatChem, 2020, 12, 2358-2384 (invited review); Org.Chem.Front., 2019, 6, 284-289. (title paper); Chem.Commun., 2020, 56, 11255-11258. Chin.J.Chem.2020, 38, 929-934. (title paper, selected as "Breaking Report”) Chem. Commun., 2021, 57, 8075-8078; Org. Chem. Front., 2021, 8, 6484–6490 (title page paper); Org. Chem. Front., 2022, 9, 2746-2752.), we believe that the development of intramolecular oxidative directing groups that are easy to introduce and transform, and the acquisition of heterocyclic pyridine compounds such as isoquinoline and naphthyridine that are compatible with strongly coordinated nitrogen heterocycles through Heck oxidation and multiple dehydrogenation cyclization reactions, has great theoretical and practical value. This transformation can not only realize the transformation from bulk chemicals to fine chemicals, but also use molecular oxygen as a co-oxidant to reduce costs, and will also solve the problem of difficult-to-control chemical selectivity and regioselectivity.
[0007] However, the above concept still faces the following challenges: 1) The Heck reaction of aryl halides with terminal olefins catalyzed by zero-valent palladium can construct olefins and heterocycles simply and selectively, and won the 2010 Nobel Prize in Chemistry. However, this type of reaction can only use terminal olefins. In recent years, the oxidative Heck reaction under the directed strategy developed by people is still often limited to terminal olefins, and 1,2-disubstituted olefins are often unreactive due to steric hindrance. 2) Complex molecular systems, especially polysubstituted aromatic rings containing strongly coordinated heterocycles such as pyrazole and pyridine, often lead to catalyst deactivation or carbon-hydrogen bond modification of non-target sites due to the influence of strongly coordinated heterocycles. It should be pointed out that there are no reports on transition metal-catalyzed oxidative Heck reactions that overcome the strong coordination limitation.
[0008] Patent application content
[0009] In order to overcome at least one problem existing in the prior art, the present patent application provides a method for preparing polysubstituted isoquinoline and 1,6-naphthyridine compounds. The preparation method in the present patent application is a Heck reaction between a phenyl o-pentanoximate containing a strongly coordinated nitrogen heterocycle and a 1,2-disubstituted olefin compound under the catalysis of a trivalent transition metal catalyst, thereby obtaining a compatible strongly coordinated dehydrogenated isoquinoline derivative or a 1,6-naphthyridine compound. This method has high atom economy and step economy, and has a wide range of substrate applicability.
[0010] Another purpose of the present patent application is to provide a common molecular skeleton of optoelectronic materials, wherein the common molecular skeleton of optoelectronic materials is a poly-substituted isoquinoline or 1,6-naphthyridine compound prepared by the following preparation method.
[0011] In order to solve the above technical problems, the technical solution adopted by this patent application is:
[0012] A method for preparing a polysubstituted isoquinoline and 1,6-naphthyridine compound comprises reacting an o-pentanoyl oxime ester (Formula II-1 or II-2) containing a strongly coordinated nitrogen heterocycle with a 1,2-disubstituted olefin compound (Formula III-1 or III-2) in an inert solvent under the action of a trivalent transition metal catalyst to obtain a polysubstituted isoquinoline or 1,6-naphthyridine compound (Formula I-1 or I-2), wherein the reaction equation is as follows:
[0013]
[0014]
[0015] Where Het is a nitrogen-containing heterocyclic ring such as pyrazole, pyridine, or triarylamine; R 1 is a hydrogen atom or a saturated alkane; R 2 It is an ester group or an aromatic group; R 3 It is a halogen atom, a triarylamine group, or the like.
[0016] Compared with the prior art, the beneficial effects of this patent application are:
[0017] The present patent application provides a method for preparing polysubstituted isoquinoline and 1,6-naphthyridine compounds. In the method, molecular oxygen is used as a co-oxidant under inert solvent conditions to rapidly construct a variety of polysubstituted isoquinoline and naphthyridine compounds by means of a trivalent rhodium-catalyzed oxidative Heck cascade reaction of 1-aryl-1-keto-o-pentanoximate. The small molecules (water, pivalic acid) are released while the method is carried out. The method is compatible with strongly coordinated nitrogen heterocycles and has multiple dehydrogenations, high atom economy and step economy. BRIEF DESCRIPTION OF THE DRAWINGS
[0018] Figure 1 The hydrogen nuclear magnetic resonance spectrum of compound 1a prepared in Example 1 of the present patent application;
[0019] Figure 2 The carbon NMR spectrum of compound 1a prepared in Example 1 of the present patent application;
[0020] Figure 3 This is the hydrogen nuclear magnetic resonance spectrum of compound 1b prepared in Example 2 of this patent application;
[0021] Figure 4The carbon NMR spectrum of compound 1b prepared in Example 2 of the present patent application;
[0022] Figure 5 This is the hydrogen nuclear magnetic resonance spectrum of compound 1c prepared in Example 3 of this patent application;
[0023] Figure 6 The carbon NMR spectrum of compound 1c prepared in Example 3 of the present patent application;
[0024] Figure 7 This is the hydrogen nuclear magnetic resonance spectrum of compound 1d prepared in Example 4 of this patent application;
[0025] Figure 8 The carbon NMR spectrum of compound 1d prepared in Example 4 of the present patent application;
[0026] Fig. 9 This is the hydrogen nuclear magnetic resonance spectrum of compound 1e prepared in Example 5 of this patent application;
[0027] Fig.10 The carbon NMR spectrum of compound 1e prepared in Example 5 of the present patent application;
[0028] Fig.11 This is the hydrogen nuclear magnetic resonance spectrum of compound 1f prepared in Example 6 of this patent application;
[0029] Fig.12 The carbon NMR spectrum of compound 1f prepared in Example 6 of the present patent application;
[0030] Fig.13 This is the hydrogen nuclear magnetic resonance spectrum of compound 1g prepared in Example 7 of this patent application;
[0031] Fig.14 This is the carbon NMR spectrum of compound 1g prepared in Example 7 of this patent application. DETAILED DESCRIPTION
[0032] The embodiments of the present patent application will be described in detail below in conjunction with the examples, but those skilled in the art will appreciate that the following examples are only used to illustrate the present patent application and should not be considered to limit the scope of the present patent application. If the specific conditions are not specified in the examples, they are carried out according to the normal conditions or the conditions recommended by the manufacturer. If the manufacturer is not specified for the reagents or instruments used, they are all conventional products that can be purchased commercially.
[0033] It should be noted that:
[0034] In this patent application, unless otherwise specified, all implementation methods and preferred implementation methods mentioned herein can be combined with each other to form a new technical solution.
[0035] In this patent application, unless otherwise specified, each reaction or operation step can be carried out sequentially or in a sequential manner. Preferably, the reaction method herein is carried out sequentially.
[0036] Unless otherwise specified, the professional and scientific terms used herein are the same as those familiar to those skilled in the art. In addition, any method or material similar or equivalent to the described content may also be applied to this patent application.
[0037] The inventors of this patent application found during the invention that in the reaction of CH activation by transition metals, the simple and diversified synthesis of heterocyclic drugs is of great synthetic significance. Common strongly coordinated nitrogen heterocycles include pyridine, pyrimidine, pyrazine, pyrazole, etc. However, when there is a strongly coordinated nitrogen heterocycle in the substrate, the nitrogen atom sp2 hybrid orbital does not participate in the aromatic construction of the heterocycle, but is occupied by a pair of lone pairs of electrons, which coordinates with the transition metal to poison the catalyst, or reacts at non-target sites. In addition, the electronegativity of the nitrogen atom is relatively large, which has a great influence on the distribution of the electron cloud density on the ring, causing the π electron cloud to shift to the nitrogen atom, with a high electron cloud density around the nitrogen atom, while the electron cloud density of other parts of the ring is reduced. Strongly coordinated nitrogen heterocycles are important components of the core skeleton of many drugs. When the conventional method is used for synthesis, the catalyst is deactivated due to the influence of the strongly coordinated nitrogen heterocycle on the reaction, and due to the guiding priority of the strongly coordinated nitrogen heterocycle, the CH activation of the target site of the guiding group is prevented, thereby reacting at non-target sites and failing to generate the expected target product. The traditional method to overcome strong coordination is to add Lewis acid to the reaction and use catalysts with few coordination sites and large steric hindrance.
[0038] In this application, the first case of the reaction of o-pentanoximate ester compatible with strongly coordinated heterocycles with 1,2 disubstituted olefins to generate polysubstituted isoquinolines and naphthyridines was achieved. The core strategies used in this application are: 1) the selection of 1,2 disubstituted olefin substrates, which are difficult to migrate and insert due to steric hindrance in conventional Heck reactions and oxidative Heck reactions, and thus have no reaction activity in Heck reactions; when there are functional groups in the substrate that can further transform with olefins, the reaction will move forward. Furthermore, if aromatization of small molecules can be achieved during the reaction, this will greatly reduce the energy barrier of the reaction, thereby achieving the priority of the reaction kinetics of the weakly coordinated directing group over the directing priority of the strongly coordinated nitrogen heterocycle, and promoting the entire reaction to proceed in the direction of regional selectivity towards the target site.
[0039] The present patent application provides a method for preparing a polysubstituted isoquinoline and 1,6-naphthyridine compound, characterized in that: in an inert solvent and under the action of a trivalent transition metal catalyst, an o-pentanoximate ester containing a strongly coordinated nitrogen heterocycle (Formula II-1 or II-2) is reacted with a 1,2-disubstituted olefin compound (Formula III-1 or III-2) to obtain a polysubstituted isoquinoline or 1,6-naphthyridine compound (Formula I-1 or I-2), and the reaction equation is as follows:
[0040]
[0041] Where Het is a nitrogen-containing heterocyclic ring such as pyrazole, pyridine, or triarylamine; R 1 is a hydrogen atom or a saturated alkane; R 2 It is an ester group or an aromatic group; R 3 It is a halogen atom, a triarylamine group, or the like.
[0042] The preparation method disclosed in this patent application has the characteristics of high efficiency, high regioselectivity, and a wide range of substrate applicability. This method can overcome the limitations of strongly coordinated heterocycles, thereby realizing non-traditional site-selective carbon-hydrogen bond modification in complex molecular systems containing multiple functional groups, thereby preparing multi-substituted isoquinoline or 1,6-naphthyridine compounds.
[0043] In some embodiments, the inert solvent is any one or more of 1,2-dichloroethane, toluene, N,N'-dimethylacetamide, N-methylpyrrolidone, dimethyl sulfoxide, and acetonitrile.
[0044] In some preferred embodiments, the trivalent rhodium metal catalyst is any one or more of pentamethylcyclopentadienyl rhodium chloride dimer, triacetonitrile-pentamethylcyclopentadienyl rhodium chloride dimer, dichlorobis(4-methylisopropylphenyl)ruthenium, and other trivalent transition metal catalysts.
[0045] In some preferred embodiments, the halide ion extractor is any one of silver bis(trifluoromethanesulfonyl)imide and silver hexafluoroantimonate, or a combination thereof.
[0046] In some preferred embodiments, the oxidant is any one or more of oxygen, sodium percarbonate, and tert-butyl peroxide.
[0047] In some preferred embodiments, the additive is sodium acetate.
[0048] In some preferred embodiments, the amount of the trivalent transition metal catalyst used is 3 mol% of the amount of the strongly coordinated nitrogen heterocyclic o-pentanoximate (Formula II-1 or II-2).
[0049] In some preferred embodiments, the reaction temperature is 85° C. and the reaction is carried out for 10 to 24 hours.
[0050] In some preferred embodiments, the preparation method of the above-mentioned polysubstituted isoquinoline and 1,6-naphthyridine compounds comprises the following steps:
[0051] Body operation steps:
[0052] S1: In a reactor, 3.3 mg of pentamethylcyclopentadiene rhodium dichloride dimer, 3.9 mg of silver trifluoromethanesulfonimide, 16.0 mg of sodium acetate, 1.0 mL of solvent 1,2-dichloroethane, 1.2 mg of solvent acetic acid, 57.0 mg of (E)-1-(4-(1H-pyrazol-1-yl)phenyl)ethan-1-one O-neopentanoic acid ester, and 38.4 mg of (E)-2-hexanoic acid methyl ester were added in sequence in air;
[0053] S2: react at 85°C for 10 hours;
[0054] S3: After the reaction is completed, the mixture is separated by column chromatography to obtain the target compound.
[0055] The present patent application also provides a common molecular skeleton of optoelectronic materials, wherein the common molecular skeleton of optoelectronic materials is a multi-substituted isoquinoline or 1,6-naphthyridine compound prepared by the above-mentioned preparation method.
[0056] Next, the preparation method and application of the polysubstituted isoquinoline and 1,6-naphthyridine compounds of the present patent application are described in detail with specific examples.
[0057] Example 1 Preparation of 1-methyl-4-propyl-6-(1H-pyrazol-1-yl)isoquinoline-3-carboxylic acid methyl ester (1a)
[0058] Under an atmospheric pressure, (E)-1-(4-(1H-pyrazol-1-yl)phenyl)ethan-1-one O-pivaloxime ester 2a (57.0 mg, 0.20 mmol), (E)-2-methyl hexanoate 3a (38.4 mg, 0.30 mmol), trivalent ruthenium catalyst [Ru(p-cymene)Cl2]2 (2.5 mg, 0.004 mmol), silver trifluoromethanesulfonimide (3.9 mg, 0.01 mmol), sodium acetate (16 mg, 0.20 mmol), sodium percarbonate (48 mg, 0.4 mmol), 1,2-dichloroethane (DCE, 0.8 mL), and acetic acid (AcOH, 1.2 mg) were added sequentially into a 15 mL Schlenk reaction tube and reacted at 85 °C for 10 hours. The crude product was separated by chromatography on a prepared silica gel plate, and the selected developing solvent was a mixed solution of petroleum ether and ethyl acetate, and the volume ratio of petroleum ether to ethyl acetate was 5:1, and the product 1-methyl-4-propyl-6-(1H-pyrazol-1-yl)isoquinoline-3-carboxylic acid methyl ester (1a) was obtained with a yield of 54%. The chemical reaction equation corresponding to this example is as follows:
[0059]
[0060] The H NMR and C NMR spectra of the compound prepared in Example 1 are as follows: Figure 1 and Figure 2 As shown. Figure 1 It can be seen that: 1 H NMR (400MHz, CDCl3) δ8.39 (d, J = 1.9Hz, 1H), 8.26 (d, J = 9.1Hz, 1H), 8.12 (d, J = 2.5Hz, 1H), 8.06 (dd, J = 9.1, 2.1Hz, 1H), 7.83 (d, J = 1.3Hz, 1H), 4.03 (s, 3H), 3.25 (dd, J = 9.1, 6.8Hz, 2H), 2.98 (s, 3H), 1.81-1.77 (m, 2H), 1.10 (t, J = 7.3Hz, 4H). The molecular hydrogen spectrum peaks can correspond to the target product one by one, and the quantity is reasonable. Figure 2 It can be seen 13 C NMR (100MHz, CDCl3) δ167.9, 156.5, 142.2, 141.0, 136.27, 132.1, 128.2, 127.1, 125.6, 120.06, 112.9, 108.7, 52.7, 31.2, 24.4, 22.5, 14.5. The molecular carbon spectrum peaks can correspond to the target product one by one, and the number is reasonable. Combined with the results of the above nuclear magnetic hydrogen spectrum and carbon spectrum, it can be seen that the product obtained in Example 1 is 1-methyl-4-propyl-6-(1H-pyrazol-1-yl)isoquinoline-3-carboxylic acid methyl ester (1a).
[0061] In this embodiment, the preparation method of 1-methyl-4-propyl-6-(1H-pyrazol-1-yl)isoquinoline-3-carboxylic acid methyl ester (1a) has few steps (one-step reaction), is easy to operate, does not require the addition of strong acid medium or strong base medium in the reaction, is green and environmentally friendly, meets the requirements of green chemistry, has good compatibility of functional groups in the reaction, and the obtained product is also easy to be further converted later. The application invention has good atom economy, and the by-product is small water or pivalic acid, with efficient step economy and atom economy. The preparation method in this embodiment has a good yield of 54%, which is conducive to the sustainable application of naphthyridine in the field of synthesis.
[0062] The preparation method in this embodiment uses (E)-1-(4-(1H-pyrazol-1-yl)phenyl)ethan-1-one O-neopentanoic acid ester 2a and 1,2-disubstituted olefin compound: (E)-2-hexanoic acid methyl ester 3a to react, thereby overcoming the problem that the oxidative Heck reaction under the directed strategy in the prior art is still often limited to terminal olefins, and 1,2-disubstituted olefins are often unreactive due to steric hindrance; at the same time, the preparation method also overcomes the problem that the oxidative Heck reaction of polysubstituted aromatic rings containing strongly coordinating heterocyclic pyrazoles often leads to catalyst deactivation or carbon-hydrogen bond modification of non-target sites due to the influence of the strongly coordinating heterocyclic ring.
[0063] The chemical transformation involved in this embodiment uses pyrazole 1-aryl-1-one o-pentanoximate as raw material, overcomes the low activity of methyl hexenoate and the difficulty of migration and insertion and the pyrazole-guided priority principle, and achieves site selectivity.
[0064] Example 2 Preparation of 1,4-dimethyl-7-(1H-pyrazol-1-yl)isoquinoline-3-carboxylic acid methyl ester (1b)
[0065] Under an atmospheric pressure oxygen atmosphere, (E)-1-(3-(1H-pyrazol-1-yl)phenyl)ethan-1-one O-pivaloxime ester 2b (57.0 mg, 0.20 mmol), methyl crotonate 3b (30.3 mg, 0.30 mmol), trivalent ruthenium catalyst [Ru(p-cymene)Cl2]2 (2.5 mg, 0.004 mmol), silver trifluoromethanesulfonimide (3.9 mg, 0.01 mmol), sodium acetate (16 mg, 0.20 mmol), 1,2-dichloroethane (DCE, 1.0 mL), and acetic acid (AcOH, 1.2 mg) were added sequentially into a 15 mL Schlenk reaction tube and reacted at 85 °C for 10 hours. The crude product was separated by chromatography using a prepared silica gel plate, and the selected developing solvent was a mixed solution of petroleum ether and ethyl acetate, and the volume ratio of petroleum ether to ethyl acetate was 5:1, and the product 1,4-dimethyl-7-(1H-pyrazol-1-yl)isoquinoline-3-carboxylic acid methyl ester (1b) was obtained with a yield of 68%. The chemical reaction equation corresponding to this example is as follows:
[0066]
[0067] The H NMR and C NMR spectra of the compound prepared in Example 2 are as follows: Figure 3 and Figure 4 As shown. Figure 3 It can be seen that: 1 H NMR (400MHz,CDCl3)δ8.27(d,J=2.0Hz,1H),8.04(dd,J=8.4,2.0Hz,1H),7.81(d,J=1.6Hz,1H),7.74(d,J=16.4Hz,1H),7.69(d,J=2.0Hz,1H),7.60(d,J=8.4Hz,1H),6.54–6.52(m,1H),6.49(d,J=16.0Hz,1H),3.78(s,3H),2.66(s,3H). The molecular hydrogen spectrum peaks can correspond to the target product one by one, and the quantity is reasonable. Figure 4 It can be seen 13 C NMR (100MHz, CDCl3) δ142.0, 127.0, 126.8, 122.3, 114.4, 108.6, 52.7, 22.6, 14.3. The molecular carbon spectrum peaks can correspond to the target product one by one, and the number is reasonable. Combining the results of the above nuclear magnetic hydrogen spectrum and carbon spectrum, it can be seen that the product prepared in Example 2 is 1,4-dimethyl-7-(1H-pyrazol-1-yl)isoquinoline-3-carboxylic acid methyl ester (1b).
[0068] In this embodiment, a multiple dehydrogenation strategy is used to react the o-pentanoximate (E)-1-(3-(1H-pyrazol-1-yl)phenyl)ethan-1-one O-pivaloxime ester 2b of an aromatic ketone containing a strongly coordinated heterocycle with methyl crotonate 3b under the promotion of a trivalent rhodium metal catalyst to undergo an oxidative Heck cascade reaction, releasing small molecules (water, pivalic acid) while rapidly constructing a variety of polysubstituted isoquinoline and naphthyridine compounds, thereby solving the problem that 1,2-disubstituted olefin compounds are difficult to migrate and insert due to steric hindrance during transition metal catalysis. At the same time, the problem that the oxidative Heck reaction of polysubstituted aromatic rings containing strongly coordinated heterocyclic pyrazoles often leads to catalyst deactivation or carbon-hydrogen bond modification of non-target sites due to the influence of the strongly coordinated heterocycle is overcome.
[0069] The reaction in this example only requires reacting at 85°C under atmospheric pressure oxygen atmosphere for 10 hours, followed by cooling and a series of subsequent treatments to obtain the final target product compound: 1,4-dimethyl-7-(1H-pyrazol-1-yl)isoquinoline-3-carboxylic acid methyl ester (1b) with a relatively high yield (68%).
[0070] The chemical conversion in this example uses methyl crotonate as a reaction raw material. Crotonic acid has a wide range of uses in industry, mainly for the preparation of various resins, bactericides, surface coatings, fungicides, plasticizers, and can also be used as an important pharmaceutical intermediate. Example 3 Preparation of 4-(N,N-dipropylsulfonyl)benzyl-1,4-dimethyl-6-(1H-pyrazol-1-yl)isoquinoline-3-carboxylate (1c)
[0071] Under an atmospheric pressure air atmosphere, (E)-1-(3-(1H-pyrazol-1-yl)phenyl)ethan-1-one O-pivaloxime ester 2a (57.0 mg, 0.20 mmol), 4-(N,N-dipropylsulfonyl)benzyl (E)-but-2-enoate 3c (101.7 mg, 0.30 mmol), trivalent rhodium catalyst [Cp*RhCl2]2 (3.3 mg, 0.004 mmol), silver trifluoromethanesulfonimide (3.9 mg, 0.01 mmol), sodium acetate (16 mg, 0.20 mmol), sodium percarbonate (48 mg, 0.4 mmol), 1,2-dichloroethane (DCE, 1.0 mL), and acetic acid (AcOH, 1.2 mg) were added sequentially into a 15 mL Schlenk reaction tube and reacted at 85 °C for 10 hours. The crude product was separated by chromatography using a prepared silica gel plate, and the selected developing solvent was a mixed solution of petroleum ether and ethyl acetate, and the volume ratio of petroleum ether to ethyl acetate was 1:1, and the product 4-(N,N-dipropylsulfonyl)benzyl-1,4-dimethyl-6-(1H-pyrazol-1-yl)isoquinoline-3-carboxylate (1c) was obtained with a yield of 40%. The chemical reaction equation corresponding to this example is as follows:
[0072]
[0073] The H NMR and C NMR spectra of the compound prepared in Example 3 are as follows: Figure 5 and Figure 6 As shown. Figure 5 It can be seen that: 1 H NMR (400MHz, CDCl3) δ8.39 (d, J = 2.0Hz, 1H), 8.26 (d, J = 9.2Hz, 1H), 8.14 (d, J = 2.4Hz, 1H), 8.08 (dd, J = 8.8, 2.0Hz, 1H), 7.83-7.81 (m, 3H), 7.63 (d, J = 8.0Hz, 2H), 6.59-6.57 (m, 1H), 5.54 (s, 2H), 3.10-3.05 (m, 5H), 2.99 (s, 3H), 2.80 (s, 3H), 1.58-1.52 (m, 4H), 0.87 (t, J = 7.6Hz, 6H). The molecular hydrogen spectrum peaks can correspond to the target product one by one, and the quantity is reasonable. Figure 6 It can be seen 13 C NMR (100MHz, CDCl3) δ167.3, 156.6, 142.2, 141.4, 140.98, 140.46, 139.9, 136.9, 128.3, 128.1, 127.6, 127.3, 127.1, 126.1, 120.1, 112.9, 108.8, 66.1, 50.0, 22.5, 22.0, 14.4, 11.2. The molecular carbon spectrum peaks can correspond to the target product one by one, and the quantity is reasonable. Combined with the results of the above nuclear magnetic hydrogen spectrum and carbon spectrum, it can be seen that the product obtained in Example 3 is 4-(N, N-dipropylsulfonyl)benzyl-1,4-dimethyl-6-(1H-pyrazol-1-yl)isoquinoline-3-carboxylate (1c).
[0074] The preparation method in this embodiment uses (E)-1-(3-(1H-pyrazol-1-yl)phenyl)ethan-1-one O-pivaloxime ester 2a and 4-(N,N-dipropylsulfonyl)benzyl (E)-but-2-enoate 3c to undergo a cascade reaction of oxidation Heck and cyclization under the catalysis of a transition metal trivalent rhodium catalyst [Cp*RhCl2]2 to obtain a polysubstituted isoquinoline compound with high regioselectivity and chemical selectivity, thereby solving the problem of regioselectivity caused by the migration and insertion of 1,2-disubstituted olefin compounds during the transition metal catalysis process.
[0075] Therefore, the preparation method and application of the polysubstituted isoquinoline compound in this embodiment is a green and efficient synthesis method. The method has the characteristics of easy availability of raw materials and high atom economy and step economy. The preparation method also overcomes the problem that the oxidative Heck reaction of the polysubstituted aromatic ring containing strongly coordinated heterocyclic pyrazoles often leads to catalyst deactivation or carbon-hydrogen bond modification of non-target sites due to the influence of the strongly coordinated heterocyclic ring.
[0076] The chemical conversion in this example reduces probenecid for drug attachment, and probenecid is a common drug used to treat gout.
[0077] Example 4 Preparation of (3-(4)-tert-butylphenyl)1-methyl-6-(1H-pyrazol-1-yl)isoquinoline (1d)
[0078] Under an atmospheric pressure air atmosphere, (E)-1-(3-(1H-pyrazol-1-yl)phenyl)ethan-1-one O-pivaloxime ester 2a (57.0 mg, 0.20 mmol), 1-(tert-butyl)-4-vinylbenzene 3d (48.3 mg, 0.30 mmol), trivalent rhodium catalyst [Cp*RhCl2]2 (3.3 mg, 0.004 mmol), silver trifluoromethanesulfonimide (3.9 mg, 0.01 mmol), sodium acetate (16 mg, 0.20 mmol), sodium percarbonate (48 mg, 0.4 mmol), 1,2-dichloroethane (DCE, 1.0 mL), and acetic acid (AcOH, 1.2 mg) were added sequentially into a 15 mL Schlenk reaction tube and reacted at 85 °C for 10 hours. The crude product was separated by chromatography using a prepared silica gel plate. The selected developing solvent was a mixed solution of petroleum ether and ethyl acetate, and the volume ratio of petroleum ether to ethyl acetate was 20:1. The product (3-(4)-tert-butylphenyl)-1-methyl-6-(1H-pyrazol-1-yl)isoquinoline (1d) was obtained with a yield of 55%. The chemical reaction equation corresponding to this example is as follows:
[0079]
[0080] The H NMR and C NMR spectra of the compound prepared in Example 4 are as follows: Figure 7 and Figure 8 As shown. Figure 7 It can be seen that: 1H NMR (400MHz, CDCl3) δ8.20 (d, J = 8.8Hz, 1H), 8.11 (q, J = 2.4Hz, 1H), 8.05 (d, J = 8.4Hz, 1H), 7.96 (dd, J = 2.4Hz, 6.8Hz, 1H), 7.91 (s, 1H), 7.81 (d, J = 2.0Hz, 1H), 7.53 (d, J = 8.4Hz, 2H), 7.40 (d, J = 8.4Hz, 1H), 7.3 (d, J = 8.4Hz, 1H), 6.55 (t, J = 2.0Hz, 1H), 3.03 (s, 3H), 1.38 (s, 9H). The molecular hydrogen spectrum peaks can correspond to the target product one by one, and the quantity is reasonable. Figure 8 It can be seen 13 C NMR (100MHz, CDCl3) δ158.4, 151.7, 151.3, 141.9, 140.6, 137.7, 136.8, 127.6, 127.0, 126.8, 125.7, 125.6, 118.7, 115.1, 114.8, 108.4, 34.7, 31.3, 22.6. The molecular carbon spectrum peaks can correspond to the target product one by one, and the quantity is reasonable. Combined with the results of the above nuclear magnetic hydrogen spectrum and carbon spectrum, it can be seen that the product obtained in Example 4 is (3-(4)-tert-butylphenyl) 1-methyl-6-(1H-pyrazol-1-yl) isoquinoline (1d).
[0081] In this embodiment, the preparation method of (3-(4)-tert-butylphenyl)1-methyl-6-(1H-pyrazol-1-yl)isoquinoline (1d) has few steps (one-step reaction), is easy to operate, does not require the addition of strong acid or strong base medium in the reaction, is green and environmentally friendly, meets the requirements of green chemistry, has good compatibility of functional groups in the reaction, and the obtained product is also easy to be further converted later. The invention of this application has good atom economy, and the by-product is small water or pivalic acid, with efficient step economy and atom economy. The preparation method in this embodiment has a good yield of 55%, which is conducive to the continuous application of isoquinoline derivatives in the field of synthesis.
[0082] The preparation method in this embodiment uses (E)-1-(4-(1H-pyrazol-1-yl)phenyl)ethan-1-one O-neopentanoic oxime ester 2a and 1-(tert-butyl)-4-vinylbenzene 3d to react, thereby overcoming the problem that the oxidative Heck reaction under the directed strategy in the prior art is still often limited to terminal olefins, and 1,2-disubstituted olefins are often unreactive due to steric hindrance; at the same time, the preparation method also overcomes the problem that the oxidative Heck reaction of polysubstituted aromatic rings containing strongly coordinating heterocyclic pyrazoles often leads to catalyst deactivation or obtains carbon-hydrogen bond modification of non-target sites due to the influence of the strongly coordinating heterocyclic ring.
[0083] The chemical conversion in this example uses tert-butylstyrene as a reaction raw material, which broadens the applicability and universality of the reaction.
[0084] Example 5 Preparation of 6-(6-methoxypyridin-3-yl)-1,4-dimethylisoquinoline-3-carboxylic acid methyl ester (1e)
[0085] Under an atmospheric pressure oxygen atmosphere, (E)-1-(4-(6-methoxypyridin-3-yl)phenyl)ethan-1-one O-pivaloxime ester 2f (65.2 mg, 0.20 mmol), methyl crotonate 3b (30.3 mg, 0.30 mmol), trivalent rhodium catalyst [Cp*RhCl2]2 (3.3 mg, 0.004 mmol), silver trifluoromethanesulfonimide (3.9 mg, 0.01 mmol), sodium acetate (16 mg, 0.20 mmol), 1,2-dichloroethane (DCE, 1.0 mL), and acetic acid (AcOH, 1.2 mg) were added sequentially into a 15 mL Schlenk reaction tube and reacted at 85 °C for 10 hours. The crude product was separated by chromatography using a prepared silica gel plate, and the selected developing solvent was a mixed solution of petroleum ether and ethyl acetate, and the volume ratio of petroleum ether to ethyl acetate was 5:1, and the product 6-(6-methoxypyridin-3-yl)-1,4-dimethylisoquinoline-3-carboxylic acid methyl ester (1e) was obtained with a yield of 55%. The chemical reaction equation corresponding to this example is as follows:
[0086]
[0087] The H NMR and C NMR spectra of the compound prepared in Example 5 are as follows: Fig. 9 and Fig.10 As shown. Fig. 9 It can be seen that: 1 HNMR (400MHz,CDCl3)δ8.53(d,J=2.4Hz,1H),8.25-8.22(m,2H),7.94(dd,J=8.8,2.8Hz,1H),7.87(dd,J=8.4,1.6Hz,1H),6.90(d,J=8.4Hz,1H),4.03(s,3H),4.02(s,3H),2.99(s,3H),2.86(s,3H). The molecular hydrogen spectrum peaks can correspond to the target product one by one, and the quantity is reasonable. Fig.10 It can be seen 13CNMR (100MHz, CDCl3) δ168.0, 164.2, 156.5, 145.7, 139.9, 137.7, 136.3, 129.1, 127.9, 127.2, 127.0, 126.8, 122.1, 111.2, 53.7, 52.7, 22.5, 14.3. The molecular carbon spectrum peaks can correspond to the target product one by one, and the quantity is reasonable. Combined with the results of the above nuclear magnetic hydrogen spectrum and carbon spectrum, it can be seen that the product obtained in Example 5 is 6-(6-methoxypyridin-3-yl)-1,4-dimethylisoquinoline-3-carboxylic acid methyl ester (1e).
[0088] In this embodiment, a multiple dehydrogenation strategy is used to react (E)-1-(4-(6-methoxypyridin-3-yl)phenyl)ethan-1-one O-pivaloxime ester 2f of an aromatic ketone containing a strongly coordinated heterocycle with methyl crotonate 3b under the promotion of a trivalent rhodium metal catalyst to undergo an oxidative Heck cascade reaction, releasing small molecules (water, pivalic acid) while rapidly constructing a variety of polysubstituted isoquinoline and naphthyridine compounds, thereby solving the problem that 1,2-disubstituted olefin compounds are difficult to migrate and insert due to steric hindrance during transition metal catalysis. At the same time, the problem that the oxidative Heck reaction of polysubstituted aromatic rings containing strongly coordinated heterocyclic pyrazoles often leads to catalyst deactivation or carbon-hydrogen bond modification of non-target sites due to the influence of the strongly coordinated heterocycle is overcome.
[0089] The reaction in this example only requires reacting at 85°C under atmospheric pressure oxygen atmosphere for 10 hours, followed by cooling and a series of subsequent treatments to obtain the final target product compound: 6-(6-methoxypyridin-3-yl)-1,4-dimethylisoquinoline-3-carboxylic acid methyl ester (1e) with a relatively good yield (55%).
[0090] In fact, pyridine is a well-known strong coordinating heterocycle. The preparation method in this embodiment can overcome the pyridine heterocycle and site-selectively form isoquinoline derivatives compatible with the pyridine nitrogen heterocycle.
[0091] Example 6 Preparation of methyl 2-chloro-5,8-dimethyl-1,6-naphthyridine-7-carboxylate (1f)
[0092] Under an atmospheric pressure air atmosphere, (E)-1-(6-chloropyridin-3-yl)ethan-1-one O-pivaloxime ester 2g (50.8mg, 0.20mmol), methyl crotonate 3b (30.3mg, 0.30mmol), trivalent rhodium catalyst [Cp*RhCl2]2 (3.3mg, 0.004mmol), silver trifluoromethanesulfonimide (3.9mg, 0.01mmol), sodium acetate (16mg, 0.20mmol), 1,2-dichloroethane (DCE, 1.0mL), and acetic acid (AcOH, 1.2mg) were added sequentially into a 15mL Schlenk reaction tube and reacted at 85°C for 10 hours. The crude product was separated by chromatography using a prepared silica gel plate, and the selected developing solvent was a mixed solution of petroleum ether and ethyl acetate, and the volume ratio of petroleum ether to ethyl acetate was 5:1, and the product 2-chloro-5,8-dimethyl-1,6-naphthyridine-7-carboxylic acid methyl ester (1f) was obtained with a yield of 74%. The chemical reaction equation corresponding to this example is as follows:
[0093]
[0094] The H NMR and C NMR spectra of the compound prepared in Example 6 are as follows: Fig.11 and Fig.12 As shown. Fig.11 It can be seen that: 1HNMR (400MHz, CDCl3) δ8.37 (d, J = 8.8Hz, 1H), 7.56 (d, J = 8.8Hz, 1H), 4.03 (s, 3H), 2.95 (s, 3H), 2.88 (s, 3H). The molecular hydrogen spectrum peaks can correspond to the target product one by one, and the quantity is reasonable. Fig.12 It can be seen 13 CNMR (100MHz,CDCl3)δ167.2,156.6,154.7,150.7,144.8,136.7,130.9,128.8,124.5,52.8,21.9,12.9. The molecular carbon spectrum peaks can correspond to the target product one by one, and the quantity is reasonable. Combining the results of the above nuclear magnetic hydrogen spectrum and carbon spectrum, it can be seen that the product obtained in Example 6 is 2-chloro-5,8-dimethyl-1,6-naphthyridine-7-carboxylic acid methyl ester (1f).
[0095] The preparation method in this embodiment uses (E)-1-(6-chloropyridin-3-yl)ethan-1-one O-neopentanoic acid ester 2g and methyl crotonate 3b to undergo a cascade reaction of oxidation Heck and cyclization under the catalysis of a transition metal trivalent rhodium catalyst [Cp*RhCl2]2 to obtain a polysubstituted isoquinoline compound with high regioselectivity and chemical selectivity, thereby solving the problem of regioselectivity caused by the migration and insertion of 1,2-disubstituted olefin compounds during the transition metal catalysis process.
[0096] Therefore, the preparation method and application of the polysubstituted isoquinoline compound in this embodiment is a green and efficient synthesis method. The method has the characteristics of easy availability of raw materials and high atom economy and step economy. The preparation method also overcomes the problem that the oxidative Heck reaction of the polysubstituted aromatic ring containing strongly coordinated heterocyclic pyrazoles often leads to catalyst deactivation or carbon-hydrogen bond modification of non-target sites due to the influence of the strongly coordinated heterocyclic ring.
[0097] The chemical transformation in this example synthesizes 1,6-naphthyridine from 1-aryl-1-keto-o-pentanoximate of pyridine heterocycle in one step. The structure of 1,6-naphthyridine contains halogen and can be used for various transformations and splicing of subsequent products.
[0098] Example 7 Preparation of methyl 2-(4-(diphenylamino)phenyl)-5,8-dimethyl-1,6-naphthyridine-7-carboxylate (1 g)
[0099] Under an atmospheric pressure oxygen atmosphere, (E)-1-(6-(4-(diphenylamino)phenyl)pyridin-3-yl)ethan-1-one O-pivaloxime ester 2h (92.6 mg, 0.20 mmol), methyl crotonate 3b (30.3 mg, 0.30 mmol), trivalent rhodium catalyst [Cp*RhCl2]2 (3.3 mg, 0.004 mmol), silver trifluoromethanesulfonimide (3.9 mg, 0.01 mmol), sodium acetate (16 mg, 0.20 mmol), 1,2-dichloroethane (DCE, 1.0 mL), and acetic acid (AcOH, 1.2 mg) were added sequentially into a 15 mL Schlenk reaction tube and reacted at 85 °C for 10 hours. The crude product was separated by chromatography using a prepared silica gel plate. The selected developing solvent was a mixed solution of petroleum ether and ethyl acetate, and the volume ratio was 1:1. The product 2-(4-(diphenylamino)phenyl)-5,8-dimethyl-1,6-naphthyridine-7-carboxylic acid methyl ester (1 g) was obtained with a yield of 64%. The chemical reaction equation corresponding to this example is as follows:
[0100]
[0101] The H NMR and C NMR spectra of the compound prepared in Example 7 are as follows: Fig.13 and Fig.14 As shown. Fig.13It can be seen that: 1HNMR (400MHz, CDCl3) δ8.40 (d, J = 8.8Hz, 1H), 8.15 (d, J = 8.8Hz, 2H), 7.97 (d, J = 8.8Hz, 1H), 7.31 (t, J = 7.6Hz, 4H), 7.18 (d, J = 7.6Hz, 6H), 7.10 (t, J = 7.2Hz, 2H), 4.04 (s, 3H), 3.00 (s, 3H), 2.94 (s, 3H). The molecular hydrogen spectrum peaks can correspond to the target product one by one, and the quantity is reasonable. Fig.14 It can be seen 13 C NMR (100MHz, CDCl3) δ167.7,159.2,156.3,150.4,150.16,147.0,143.7,134.4,131.3,131.1,129.4,128.7,125.3,123.9,122.1,121.6,119.6,77.3,77.0,76.7,52.6,21.7,12.8. The molecular carbon spectrum peaks can correspond to the target product one by one, and the quantity is reasonable. Combined with the results of the above nuclear magnetic hydrogen spectrum and carbon spectrum, it can be seen that the product obtained in Example 6 is 2-(4-(diphenylamino)phenyl)-5,8-dimethyl-1,6-naphthyridine-7-carboxylic acid methyl ester (1g).
[0102] In this embodiment, the preparation method of 2-(4-(diphenylamino)phenyl)-5,8-dimethyl-1,6-naphthyridine-7-carboxylic acid methyl ester (1g) has few steps (one-step reaction), is easy to operate, does not require the addition of strong acid medium or strong base medium in the reaction, is green and environmentally friendly, meets the requirements of green chemistry, has good compatibility of functional groups in the reaction, and the resulting product is also easy to be further converted subsequently. The invention of this application has good atom economy, and the by-product is small water or pivalic acid, with efficient step economy and atom economy. The preparation method in this embodiment has a high yield of 64%, which is conducive to the continuous application of 1,6-naphthyridine derivatives in the field of synthesis.
[0103] The preparation method in this embodiment uses (E)-1-(6-(4-(diphenylamino)phenyl)pyridin-3-yl)ethan-1-one O-neopentanyl oxime ester 2h and methyl crotonate 3b to react, thereby overcoming the problem that the oxidative Heck reaction under the directed strategy in the prior art is still often limited to terminal olefins, and 1,2-disubstituted olefins are often unreactive due to steric hindrance; at the same time, the preparation method also overcomes the problem that the oxidative Heck reaction of polysubstituted aromatic rings containing strongly coordinating heterocyclic pyrazoles often leads to catalyst deactivation or obtains carbon-hydrogen bond modification of non-target sites due to the influence of strongly coordinating heterocyclic rings.
[0104] The chemical transformation in this example connects triarylamine groups, which are common molecular backbones for optoelectronic materials.
[0105] In summary, this patent application relates to a trivalent rhodium-catalyzed oxidative Heck reaction that overcomes the limitations of strongly coordinated heterocycles under a directed strategy, that is, utilizing a traceless directed oxidative Heck reaction of 1-aryl-1-keto-o-pentanoximate and 1,2-disubstituted olefins to achieve a simple construction of isoquinoline derivatives or 1,6-naphthyridine compounds that are compatible with multiple dehydrogenations of strongly coordinated heterocycles, and further develop their connection and transformation in the skeleton of drugs and optoelectronic materials.
[0106] This patent application discloses a site-selective carbon-hydrogen bond activation that overcomes the limitation of strongly coordinated heterocycles, thereby simply constructing isoquinoline derivatives or 1,6-naphthyridine compounds, realizing isoquinoline derivatives or 1,6-naphthyridine compounds with site-selective oxidation and oxidative Heck reactions compatible with strong coordinating groups; specifically, under inert solvent conditions, through the joint promotion of trivalent rhodium catalyst and oxidant, N-OPiv containing strongly coordinated heterocycles is used as a directing group with 1,2-disubstituted olefin compounds, overcoming the problems of strongly coordinated heterocycle directing priority and catalyst poisoning, and realizing oxidative Heck coupling reaction. This method has atomic and step economy, and has a wide range of substrate applications.
[0107] In the description of this specification, the description with reference to the terms "one embodiment", "some embodiments", "illustrative embodiments", "examples", "specific examples", or "some examples" means that the specific features, structures, materials or characteristics described in conjunction with the embodiments or examples are included in at least one embodiment or example of this patent application. In this specification, the schematic representation of the above terms does not necessarily refer to the same embodiment or example. Moreover, the specific features, structures, materials or characteristics described may be combined in any one or more embodiments or examples in a suitable manner.
[0108] Although several embodiments of the present patent application have been shown and described, those skilled in the art will appreciate that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present patent application, and the scope of the present patent application is defined by the claims and their equivalents.
Claims
1. A method for preparing a polysubstituted isoquinoline and 1,6-naphthyridine compound, characterized in that: In an inert solvent, and under the action of a trivalent transition metal catalyst, a halide ion extractor, an oxidant and an additive, formula II-1 is reacted with formula III-1 to obtain formula I-1, or II-2 is reacted with III-2 to obtain formula I-2, and the reaction equation is as follows: ; or ; Wherein Het is pyrazole or pyridine; R 1 is n-propyl or methyl; R 2 -CO2Me or or ; R 3 Halogen or ; The inert solvent is 1,2-dichloroethane; The trivalent transition metal catalyst is any one of pentamethylcyclopentadienyl rhodium chloride dimer, triacetonitrile-pentamethylcyclopentadienyl rhodium chloride dimer, and dichlorobis(4-methylisopropylphenyl)ruthenium; The halide ion extractor is silver bis(trifluoromethanesulfonyl imide); The oxidant is any one of oxygen and sodium percarbonate; The additive is sodium acetate.
2. The method for preparing a polysubstituted isoquinoline and 1,6-naphthyridine compound according to claim 1, characterized in that: The amount of the trivalent transition metal catalyst used is 3 mol% of the amount of Formula II-1 or II-2.
3. The method for preparing a polysubstituted isoquinoline and 1,6-naphthyridine compound according to claim 1, characterized in that: The reaction temperature is 85° C. and the reaction is carried out for 10 to 24 hours.
4. A method for preparing a polysubstituted isoquinoline compound, characterized in that: The specific steps include the following: S1: In a reactor, in air, 3.3 mg of pentamethylcyclopentadiene rhodium dichloride dimer, 3.9 mg of silver trifluoromethanesulfonimide, 16.0 mg of sodium acetate, 1.0 mL of solvent 1,2-dichloroethane, 1.2 mg of acetic acid, 57.0 mg of the compound of formula 2a, and 38.4 mg of the compound of formula 3a were added in sequence, wherein the structural formulas of the compound of formula 2a and the compound of formula 3a are as follows: , ; S2: react at 85°C for 10 hours; S3: After the reaction is completed, the mixture is separated by column chromatography to obtain the target compound 1a, whose structural formula is as follows: 。
